Canadian trial: Remdesivir reduces need for ventilation by half for COVID-19 patients
A Canadian study suggests the antiviral medication remdesivir could have a "modest but significant effect" on COVID-19 patient outcomes, including decreasing the need for mechanical ventilation by approximately 50 per cent.
The study, published Wednesday in the Canadian Medical Association Journal, is billed as the largest single-country trial of remdesivir reported to date.
Results are part of a larger study called the World Health Organization Solidarity, a randomized, controlled trial evaluating remdesivir's impact on COVID-19 patients in several countries.
Researchers at the University of British Columbia and Sunnybrook Health Sciences Centre in Toronto recruited 1,282 patients at 52 hospitals between Aug. 14, 2020 and April 1, 2021. Roughly half received a 10-day course of remdesivir while the other half got the usual level of care.
Among participants not on ventilation at the start of the study, eight per cent of the remdesivir group -- 46 patients -- went on to require a ventilator compared to 15 per cent, or 89 patients, who received standard care.
The study also found patients on remdesivir came off oxygen and ventilators sooner.
Evidence has been mixed on the effect of remdesivir in people with COVID-19. The World Health Organization recommended against using it to treat the virus in November 2020, saying at the time "there is currently no evidence that remdesivir improves survival and other outcomes."
Remdesivir, which is administered intravenously, is a repurposed antiviral medication originally developed to treat hepatitis C.
Dr. Robert Fowler, a senior scientist at Sunnybrook and co-author of the study, said earlier recommendations against remdesivir stemmed from premature data that didn't show a statistically significant impact on COVID-19 patients.
He said the Canadian trial results could reverse opinions on the treatment, however.
"We'll probably help a number of other countries that have similar health-care systems in terms of resources to say: 'OK. ... (remdesivir) seems it has a number of positive effects," Fowler said.
"It will probably move the needle towards people having much more confidence the medication is effective for certain outcomes."
Fowler said he expects the WHO to release results from the Solidarity trial's other participating nations within the next couple of months.
The Canadian arm, funded by the Canadian Institutes of Health Research, collected more detailed data than some other countries and included patients across a range of ethnicities.
The study also looked at in-hospital mortality, which was slightly lower in the remdesivir group at 18.7 per cent, compared to 22.6 in the control group. Fowler said those figures weren't statistically significant "in absolute terms."
While the study period ended before Omicron arrived in Canada, Fowler said remdesivir is likely to have the same effect on those hospitalized with the variant.
He added that effective COVID-19 treatments are critical at this stage of the pandemic as soaring case counts have overwhelmed health-care systems across the country.
Publication of the study came two days after Health Canada authorized use of the take-home Pfizer antiviral pill Paxlovid, meant to reduce hospitalizations in those at higher risk of severe COVID-19 disease.
"It becomes critical that your next line of treatments are effective and growing," Fowler said.
"I would say, luckily, and with a lot of hard work behind it, there are an increasing number of medications, this one included ... to help patients survive and to get out of hospital sooner."
This report by The Canadian Press was first published Jan. 19, 2021.
COVID-19 COVERAGE
CTVNews.ca Top Stories
LIVE UPDATES | Alberta election live updates: Elections Alberta says it's not experiencing issues
CTV News has declared a number of seats across the province as election results begin to take shape Monday night.

Albertans head to polls in what's expected to be very close election between UCP, NDP
In Alberta today, the United Conservative Party is looking to win a second consecutive majority government while the NDP is fighting to regain the office it lost in 2019.
Singh calling for foreign interference special rapporteur Johnston to step aside
NDP Leader Jagmeet Singh is pushing for special rapporteur David Johnston to 'step aside' from his role examining the issue of foreign interference before he embarks on public hearings.
New Democrat MP says she is target of foreign interference by China
New Democrat MP Jenny Kwan said Monday that Canada's spy agency has confirmed her long-held belief she is being targeted by the Chinese government, as the prime minister granted the NDP's wish to allow more party members to review top-secret intelligence.
Golden Knights reach 2nd Stanley Cup Final after Game 6 win over Stars
William Karlsson, William Carrier and Jonathan Marchessault are finally getting another chance in the Stanley Cup Final, after the first one that came so quick for the Vegas Golden Knights.
Caleb Martin helps Heat to 103-84 Game 7 win over Celtics and spot in NBA Finals
Eastern Conference finals Most Valuable Player Jimmy Butler scored 28 points, and Caleb Martin had 26 points and 10 rebounds to help the eighth-seeded Miami Heat beat the Celtics 103-84 in Game 7 on Monday night and advance to the NBA Finals for the second time in four seasons.
Canadian parliamentarians condemn Uganda's recently passed anti-homosexuality law
Canadian political leaders and parliamentarians are denouncing a new law passed in Uganda that imposes harsh penalties, including the death penalty, for certain cases involving homosexuality.
Free prescription drugs could reduce overall health-care costs in Canada: study
Overall health-care costs could be reduced in Canada by providing free prescription drugs to patients, according to a new study.
Northern B.C., Alberta and all of Ontario under 'high' to 'extreme' wildfire risk: What to know
There's a heightened risk of wildfires across the country during what has been one of the earliest fire seasons on record. From British Columbia to Nova Scotia, here's where the risk is highest.